CSI Market
Sign In | Register

Cadence Pharmaceuticals Inc (CADX) Annual Balance Sheets

Annual · GAAP · USD millions
Access CADX quarterly Balance Sheets →
Examining balance sheet movements between Cadence Pharmaceuticals Inc and reveals how Dec 31 2013 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CADX/balance-sheets
https://api.csimarket.com/api/v1/companies/CADX/fundamentals
https://api.csimarket.com/api/v1/companies/CADX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2013)
(Dec 31 2012) (Dec 31 2010)
Assets
Cash & cash equivalent55.08
Restricted Cash and Investments, Current, Total0.55
Available-for-sale Securities, Current MA2.33
Cash & Short-term Investments57.00
Accounts receivable9.30
Inventories8.65
Other Current Assets0.09
Prepaid Expense, Current AS1.90
Total Current Assets77.89
Equipment/Property/Plant Net2.06
Intangible Assets10.75
Long-term investments0.09
Other Assets, Noncurrent0.02
Total Assets90.80
Liabilities
Accounts Payable, Current AC7.72
Accrued Liabilities, Current AC18.04
Long-term Debt, Current Maturities LO10.78
Deferred Revenue, Current DE0.00
Total Current Liabilities36.54
Long-term debt18.54
Total Long-term Debt18.54
Other liabilities, Noncurrent0.84
Total Liabilities55.93
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock506.82
Retained Earnings / Accumulated Deficit-471.95
Other Equity0.00
Common Stockholder's Equity34.88
Total Stockholder's Equity34.88
Liabilities & Stockholder's Equity90.80
4 historic quarters locked

Sign in to unlock the full Cadence Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About CADX Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI